Tue, Dec 23, 2014
A A A
Welcome Guest
Free Trial RSS
Get FREE trial access to our award winning publications
New Managers June 2012

Servicers' Spot - BNY Mellon: Do not underestimate the extent of upcoming regulations

BNY Mellon: Do not underestimate the extent of upcoming regulations

Mark Mannion

Mark Mannion, head of relationship management for EMEA at BNY Mellon Alternative Investment Services, an awardwinning fund administrator, believes that fund managers should not underestimate the extent of upcoming regulations - especially in three very important areas.

First, Mannion told Opalesque in an interview, from the U.S. perspective, managers will have to register with the SEC. And "subject to certain thresholds and exemptions, they may need to file very extensive Form PFs on a quarterly basis."

Indeed, the new SEC rule requires investment advisers registered with the SEC who advise one or more private funds and have at least $150 million in private fund assets under management to file Form PF with the SEC - effective March 31, 2012.

As significant amounts of portfolio data have to be included in that Form, BNY Mellon can help fund managers through its completion to ensure they are compliant with the SEC's requirements.

The second area is FATCA. Foreign Account Tax Compliance Act (FATCA) is part of U.S. efforts to improve tax compliance involving foreign financial assets and offshore accounts.

"Funds now need to put themselves into a position where they will be ready to comply with the FATCA Act in 2014," Mannion explains. "At the point of launch, we ensure that the new hedge fund's application forms and documentation will work from a FATCA perspective, by collecting that information that you need in order to set-up each investor on the correct basis in the Transfer Agency S......................

To view our full article please login

This article was published in Opalesque's New Managers a top-down monthly analysis, news and research publication on the global emerging manager space.
New Managers
New Managers
New Managers

Today's Exclusives Today's Other Voices More Exclusives
Previous Opalesque Exclusives                                  
More Other Voices
Previous Other Voices                                               
Access Alternative Market Briefing


  • Top Forwarded
  • Top Tracked
  • Top Searched
  1. Investing - Big hedge funds win again on PetSmart, Riverbed, RBS sells real estate loans to hedge fund Cerberus, Talisman energy speculation: Which hedge funds could benefit?[more]

    Big hedge funds win again on PetSmart, Riverbed From CNBC.com: Another week, another set of wins for activist investors. On Sunday, pet supply retailer PetSmart agreed to the largest leveraged buyout of the year at $8.7 billion. Hedge fund firm JANA Partners had been pushing for a sale a

  2. Outlook - Hedge fund manager who remembers 1998 rout says prepare for pain, Bond guru Bill Gross predicts U.S. economic growth to dip to 2%[more]

    Hedge fund manager who remembers 1998 rout says prepare for pain From Bloomberg.com: Stephen Jen landed in Hong Kong in early January 1997 as Morgan Stanley’s newly minted exchange-rate strategist for Asia. He was soon working around the clock when investors began targeting the region’s

  3. Investing - Hedge funds get boost from healthcare in 2014, Paulson & Co takes stake in Salix on heels of inventory issues[more]

    Hedge funds get boost from healthcare in 2014 From Valuewalk.com: The healthcare sector started the year on a turbulent note, as stocks of many major biotechnology companies were battered. However, most of the players in this sector have bounced back. The BarclayHedge Healthcare & Biotec

  4. North America - Why Steve Cohen, Connecticut hedge fund billionaire, gives so much in New York[more]

    From Insidephilantrophy.com: Billionaire Steve Cohen was born in Great Neck, New York before attending Wharton, working on Wall Street and then founding SAC Capital Advisors in Connecticut. Though his company (Point72) and foundation are based in Connecticut, Cohen and Alexandra are deeply connected

  5. Investing - Soros buys a highly speculative biotech in the third quarter[more]

    From Fool.com: …The Soros Fund bought 25,000 shares of the struggling small-cap biopharma Aegerion Pharmaceuticals in the third quarter. For those of you who haven't heard of this name, suffice to say that this was a surprising buy in light of the company's recent problems and poor outlook going for